Evidence map›Paper›PMID 23337976›Full record

ArticleInternational journal of oncology2013

Delta-like 3 is silenced by methylation and induces apoptosis in human hepatocellular carcinoma.

Kentaro Maemura, Hirohide Yoshikawa, Kazutake Yokoyama, Teruo Ueno, Hitomi Kurose, Kazuhisa Uchiyama, Yoshinori Otsuki

Open access · hybridAbstract read
In one paragraph

Article in International journal of oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Current research of the Notch pathway in hepatocellular carcinoma.European journal of medical research · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Diagnostic and prognostic value ofFrontiers in immunology · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. [Over-expression of human Notch ligand Delta-like 3 promotes proliferation of human gastric cancer cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kentaro MaemuraDepartment of Anatomy and Cell Biology, Osaka Medical College, Takatsuki, Osaka, Japan. an2011@art.osaka-med.ac.jp
Hirohide Yoshikawa
Kazutake Yokoyama
Teruo Ueno
Hitomi Kurose
Kazuhisa Uchiyama
Yoshinori Otsuki
Osaka Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetic and epigenetic events of hepato-carcinogenesis are relatively poorly understood. By analyzing genes from human hepatocellular carcinoma (HCC) with restriction landmark genomic scanning, several aberrantly methylated genes, including Delta-like 3 (DLL3), have been isolated. In this study, we investigated the function of DLL3 in hepatocarcinogenesis. Methylation of the DLL3 gene in HCC cell lines was investigated with methylation-specific PCR and expression of DLL3 mRNA in HCC cells was examined by RT-PCR. Reactivation of DLL3 expression by treatment with a demethylating agent was examined in methylation-silenced HuH2 cells. Human DLL3 cDNA was cloned and DLL3 function was examined by restoring DLL3 expression in HuH2 cells. The effects of DLL3 on cell growth were evaluated by colony formation assay. Induction of cell death by overexpression of DLL3 was examined by flow cytometric assay using Annexin V and PI. Apoptotic cells were detected by TUNEL staining and the amount of single-stranded DNA was measured by ELISA. As a result, the promoter region of the DLL3 gene was methylated in four of ten HCC cell lines. This aberrant methyl-ation correlated well with the suppression of RNA expression and a demethylating agent reactivated DLL3 expression in methylation-silenced HCC cells. Interestingly, the restoration of DLL3 in the methylation-silenced HuH2 cells led to growth suppression on colony formation assay. Flow cytometric assay with Annexin V and PI showed that this growth suppression by DLL3 expression is associated with the induction of apoptosis. Furthermore, these apoptotic effects were confirmed by TUNEL staining and measurement of single-stranded DNA. These results suggest that DLL3 was silenced by methylation in human HCC and that it negatively regulates the growth of HCC cells.

Indexed as

ApoptosisDNA MethylationCarcinoma, HepatocellularCell Line, TumorCell ProliferationCpG IslandsEnzyme ActivationGene Expression Regulation, NeoplasticGene SilencingHumansIntracellular Signaling Peptides and ProteinsLiver NeoplasmsMembrane ProteinsPromoter Regions, GeneticReceptor, Notch1RNA, MessengerDLL3 protein, humanIntracellular Signaling Peptides and ProteinsMembrane ProteinsNOTCH1 protein, humanReceptor, Notch1RNA, Messenger

Identifiers

PMID23337976
PMCPMC3597457
OpenAlexW2012334452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.